KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:AGTC
Delisted

Applied Genetic Technologies Corporation Stock Price (Quote)

$0.397
+0 (+0%)
At Close: Feb 28, 2023

Range Low Price High Price Comment
30 days $0.397 $0.397 Tuesday, 28th Feb 2023 AGTC stock ended at $0.397. During the day the stock fluctuated 0% from a day low at $0.397 to a day high of $0.397.
90 days $0.370 $0.400
52 weeks $0.230 $2.03

Historical Applied Genetic Technologies Corporation prices

Date Open High Low Close Volume
Sep 06, 2019 $3.41 $3.90 $3.32 $3.76 331 157
Sep 05, 2019 $3.30 $3.30 $3.14 $3.20 60 184
Sep 04, 2019 $3.27 $3.29 $3.14 $3.29 36 914
Sep 03, 2019 $3.31 $3.31 $2.88 $3.16 82 945
Aug 30, 2019 $2.97 $3.23 $2.91 $3.16 49 604
Aug 29, 2019 $2.61 $3.03 $2.60 $2.98 169 132
Aug 28, 2019 $2.52 $2.75 $2.52 $2.60 154 887
Aug 27, 2019 $2.73 $2.87 $2.56 $2.59 73 025
Aug 26, 2019 $2.88 $2.99 $2.70 $2.70 59 246
Aug 23, 2019 $2.99 $3.04 $2.85 $2.88 69 601
Aug 22, 2019 $3.07 $3.07 $2.95 $3.00 18 700
Aug 21, 2019 $2.96 $3.17 $2.95 $3.00 64 883
Aug 20, 2019 $3.16 $3.23 $2.96 $2.97 132 817
Aug 19, 2019 $3.10 $3.24 $3.09 $3.18 158 018
Aug 16, 2019 $2.96 $3.18 $2.75 $3.08 178 575
Aug 15, 2019 $3.53 $3.53 $2.83 $3.00 366 124
Aug 14, 2019 $3.41 $3.63 $3.41 $3.47 187 170
Aug 13, 2019 $3.73 $3.79 $3.27 $3.51 198 138
Aug 12, 2019 $3.75 $3.85 $3.67 $3.68 51 420
Aug 09, 2019 $3.85 $4.00 $3.73 $3.83 95 974
Aug 08, 2019 $3.90 $3.90 $3.73 $3.85 92 270
Aug 07, 2019 $3.85 $3.98 $3.76 $3.86 54 484
Aug 06, 2019 $3.87 $3.91 $3.68 $3.85 120 730
Aug 05, 2019 $3.96 $3.96 $3.79 $3.91 30 230
Aug 02, 2019 $3.91 $4.00 $3.85 $3.95 29 688
Click to get the best stock tips daily for free!

About Applied Genetic Technologies Corporation

Applied Genetic Technologies Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing... AGTC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT